Jean-Marc NACCACHE
Groupe Hospitalier Paris Saint Josèphe · Fondation Hôpital Saint-Joseph · Assistance Publique - Hôpitaux de Paris
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Jean-Marc NACCACHE as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 05:47 UTC. Open this list on ClinicalTrials.gov
- N/ANCT07457502 · Domestic Environmental Exposure and Progression of ILD: An Exploratory Case-Control StudyVille de Paris · recruiting · Assess PID Diagnosis Revision After CMEI Audit, Assess CMEI Recommendations' Impact on Respiratory Health, ILD Progression and Exposure to Indoor Environnemental Risk · principal investigator
- Ph3NCT05674994 · Glucocorticoids Versus Placebo for the Treatment of Acute Exacerbation of Idiopathic Pulmonary FibrosisFondation Hôpital Saint-Joseph · recruiting · Acute Exacerbation of Idiopathic Pulmonary Fibrosis · study director
- N/ANCT05449431 · Comparison of the 1-min Sit-to-Stand Test to the 6-minute Walk Test in the Respiratory Functional Assessment of Pulmonary FibrosisFondation Hôpital Saint-Joseph · unknown · Idiopathic Pulmonary Fibrosis
- Ph3NCT04365582 · OUTpatient Treatment of COVID-19 in Patients With Risk Factor for Poor OutcomeFondation Hôpital Saint-Joseph · withdrawn · COVID · principal investigator
- Ph3NCT02460588 · Cyclophosphamide for Acute Exacerbation of Idiopathic Pulmonary FibrosisAssistance Publique - Hôpitaux de Paris · completed · Idiopathic Pulmonary Fibrosis · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 05:47 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 05:47 UTC. The ranking covers the 200 most relevant of 6 PubMed records, and a shared surname and initials can bring in a namesake. All 6 on PubMed
- Early Chest Computed Tomography Scan to Assist Diagnosis and Guide Treatment Decision for Suspected Community-acquired Pneumonia.Am J Respir Crit Care Med · 2015232 citationsRCR 9.4
- Rituximab and mycophenolate mofetil combination in patients with interstitial lung disease (EVER-ILD): a double-blind, randomised, placebo-controlled trial.Eur Respir J · 2023120 citationsRCR 15.0
- Cyclophosphamide added to glucocorticoids in acute exacerbation of idiopathic pulmonary fibrosis (EXAFIP): a randomised, double-blind, placebo-controlled, phase 3 trial.Lancet Respir Med · 2022104 citationsRCR 8.9
- Inhaled ciclesonide for outpatient treatment of COVID-19 in adults at risk of adverse outcomes: a randomised controlled trial (COVERAGE).Clin Microbiol Infect · 202227 citationsRCR 1.5
- 13 citationsRCR 0.7
- Rituximab and mycophenolate mofetil in interstitial lung disease (EVER-ILD): 1-year follow-up results of a randomised controlled trial.Eur Respir J · 20245 citationsRCR 0.9